Strengthening the comprehensive management of concomitant diseases of breast cancer: cardiac toxicity management in breast cancer treatment
CHEN Kun
GAO Dian-sa
ZUO Zhong
Abstract：Breast cancer is the most common malignant tumor in Chinese women. At present, the survival rate of breast cancer patients has been gradually elevated by using comprehensive treatment methods such as surgery, radiotherapy and chemotherapy, endocrine therapy and targeted therapy. However, the cardiotoxicity caused by the above treatments has become a common cause of death for cancer survivors, so it is necessary to evaluate cardiotoxicity and protect the heart during the treatments of breast cancer. This article focuses on the management of cardiotoxicity caused by breast cancer related therapies.
Keywords：Breast cancer therapyCardiotoxicityCardiac protection
Publication Date：2019-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：5( 125-129 )